Home » Topics » BioWorld Science

BioWorld Science
RSS

Primmune Therapeutics discloses new TLR7 agonists

Dec. 11, 2019

Constellation Pharmaceuticals patents EZH2 inhibitors

Dec. 11, 2019

Xeris reports in-clinic stage data from phase II trial of RTU glucagon

Dec. 11, 2019

Three phase III trials of tralokinumab in atopic dermatitis meet endpoints

Dec. 11, 2019

GenSight reports on REALITY registry study in support of Lumevoq

Dec. 11, 2019

The anti-CD33/CD3 BiTE AMG-673 shows promise as treatment for relapsed/refractory AML

Dec. 11, 2019

First-in-human study of LOXO-305 confirms it as a potent anti-BTK agent for B-cell malignancies

Dec. 11, 2019

Pfizer gives details on the discovery of novel noncovalent modulator of hemoglobin

Dec. 11, 2019

Anti-BCMA CAR-T candidate C-CAR088 shows early clinical efficacy

Dec. 11, 2019

Implicit Bioscience presents phase I data for IC-14 in motor neuron disease

Dec. 11, 2019

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...